Childhood Immunisation: The UK Vaccination Schedule Explained

Childhood Immunisation: The UK Vaccination Schedule Explained

newborn: 0–5 years4 min read
Share:

The UK childhood immunisation schedule is one of the most evidence-based and carefully constructed public health interventions available, protecting against diseases that caused significant childhood illness and death before vaccines were available. Understanding what is offered, when, and why — and having accurate information about the safety evidence — helps parents approach immunisation with confidence.

Healthbooq supports parents with evidence-based guidance on childhood health, including the immunisation schedule and the evidence behind its safety and effectiveness.

Why the Schedule Is Designed the Way It Is

The timing of each vaccine in the schedule is determined by the age at which the immune system can generate a protective response and by the risk of the disease in question. Some vaccines (like the six-in-one at eight weeks) are given as early as possible because the diseases they protect against — whooping cough in particular — are most dangerous in the youngest infants. Others are given later because maternal antibodies (passed through the placenta) provide some early protection that interferes with vaccine efficacy if given too soon.

Multiple vaccines given at the same visit do not overwhelm the immune system. The immune system of a healthy infant can mount responses to hundreds of antigens simultaneously; the small number in any vaccine schedule is entirely manageable.

The Schedule at a Glance

Eight weeks: The six-in-one vaccine (diphtheria, tetanus, pertussis/whooping cough, polio, Haemophilus influenzae type b, hepatitis B) as an injection; the MenB vaccine (meningitis B); and the Rotarix vaccine (rotavirus), given orally.

Twelve weeks: The six-in-one second dose; the PCV (pneumococcal) vaccine; the Rotarix second dose.

Sixteen weeks: The six-in-one third dose; the MenB second dose.

Twelve months: The Hib/MenC booster; the MMR vaccine (measles, mumps, rubella) first dose; PCV booster; MenB booster.

Three years and four months (pre-school boosters): MMR second dose; the four-in-one (diphtheria, tetanus, pertussis, polio) pre-school booster.

Flu vaccine: Offered annually as a nasal spray to all children aged two to sixteen years. The first dose is offered to children aged two and three years at their GP surgery in the autumn.

Common Side Effects

Normal reactions to vaccinations include redness, swelling, and tenderness at the injection site; mild fever; irritability and crying for a few hours after the vaccination; and drowsiness. These reactions indicate the immune system is responding and are expected. They typically resolve within twenty-four to forty-eight hours. Paracetamol can be used to manage fever and discomfort; the specific advice for MenB (offered at eight and sixteen weeks) is to give a dose of paracetamol liquid infant suspension shortly before or after the vaccination to reduce the risk of fever.

Serious adverse reactions to vaccines are rare. The MHRA (Medicines and Healthcare products Regulatory Agency) monitors vaccine safety on an ongoing basis.

The MMR Vaccine and Autism: The Evidence

The claim that the MMR vaccine causes autism originates from a 1998 paper by Andrew Wakefield, which was found to be fraudulent — Wakefield had manipulated data and had undisclosed financial conflicts of interest. The paper was retracted by The Lancet in 2010, and Wakefield was struck off the medical register.

Subsequent research involving millions of children across multiple countries and independent research groups has found no link between the MMR vaccine and autism. The epidemiological evidence on this question is among the most extensively studied in all of vaccine research. The initial paper was fraudulent, and the extensive subsequent research has consistently found no association.

Declining Vaccination

Parents who have concerns about specific vaccines are encouraged to discuss these with their GP or health visitor, who can provide individualised information. The strong scientific consensus is that the risks of the diseases vaccines protect against substantially outweigh any risks from the vaccines themselves. Declining vaccination does not only affect the individual child — it affects the herd immunity that protects children who are too young to be vaccinated or who cannot be vaccinated for medical reasons.

Key Takeaways

The NHS childhood vaccination schedule provides protection against fourteen serious diseases from eight weeks of age through to school-entry immunisations. Vaccines on the schedule are rigorously tested for safety and efficacy, and the timing of each vaccine is calibrated to provide protection as early as possible. The immunisation schedule is free on the NHS and offered through GP surgeries. Common questions about vaccine safety — including the extensively researched and definitively disproven claim of a link between the MMR vaccine and autism — have been addressed by multiple large-scale independent studies. A brief guide to what each set of vaccines protects against and typical side effects supports parents in giving informed consent.